Recruiting
Phase 2

Lymphoma Treatment

Sponsor:

SWOG Cancer Research Network

Code:

NCT05890352

Conditions

Grade 3b Follicular Lymphoma

High Grade B-Cell Lymphoma

High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

Recurrent Diffuse Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Lenalidomide

Magnetic Resonance Imaging

Positron Emission Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-23. This information was provided to ClinicalTrials.gov by SWOG Cancer Research Network on 2025-10-20.